Log In
Sunday 18th March 2018

US approves GSK triple lung drug

19th September 2017

US regulators have approved GlaxoSmithKline's three-in-one inhaler for chronic lung disease.

Click on available sources in right hand menu to see the original article.

Share this page


There are no comments for this article, be the first to comment!

Post your comment

Only registered users can comment. Fill in your e-mail address for quick registration.

Your email address:

Your comment will be checked by a Healthcare Today moderator before it is published on the site.

Article Information

Title: US approves GSK triple lung drug
Author: Martine Hamilton
Article Id: 28925
Date Added: 19th Sep 2017


Reuters News

Recent Related Articles

Prescription drug addiction to be reviewed


Add to scrapbook
Show Comments
Add comment
Find all related articles


Mayden - Innovative cloud-based web development for the healthcare sector
© Mayden Foundation 2018